Stone Ridge Asset Management’s Haemonetics HAE Stock Holding History

Stone Ridge Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,122	Closed	-$369K	–	198
2020 Q2	$369K	Sell	4,122 -10,995	-73%	-$1.11M	0.06%	357
2020 Q1	$1.51M	Hold	15,117	–	–	0.16%	110
2019 Q4	$1.74M	Hold	15,117	–	–	0.1%	239
2019 Q3	$1.91M	Hold	15,117	–	–	0.11%	215
2019 Q2	$1.82M	Hold	15,117	–	–	0.11%	222
2019 Q1	$1.32M	Hold	15,117	–	–	0.08%	331
2018 Q4	$1.51M	Hold	15,117	–	–	0.09%	259
2018 Q3	$1.73M	Hold	15,117	–	–	0.09%	247
2018 Q2	$1.36M	Hold	15,117	–	–	0.08%	290
2018 Q1	$1.11M	Hold	15,117	–	–	0.06%	348
2017 Q4	$878K	Buy	+15,117	New	+$796K	0.05%	456

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stone Ridge Asset Management's HAE Position: Q3 2020 in Review

Stone Ridge Asset Management sold out of Haemonetics (HAE) in Q3 2020, closing a stake of 4,122 shares — an estimated $369K sold.

Stone Ridge Asset Management first reported a position in HAE in Q4 2017 and held it in 11 quarters. The position peaked at $1.91M in Q3 2019. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2020.

Stone Ridge Asset Management reported no remaining Haemonetics position as of Q3 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 4,122 Haemonetics shares in Q3 2020, an estimated $369K.
Stone Ridge Asset Management first reported a position in Haemonetics in Q4 2017 and held it in 11 quarters.
Stone Ridge Asset Management's Haemonetics position peaked at $1.91M in Q3 2019.
268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2020.

Based on Stone Ridge Asset Management's 13F filing for Q3 2020.